Virus Inactivation during Intravenous Immunoglobulin Production
- 1 August 1992
- journal article
- Published by Wiley in Vox Sanguinis
- Vol. 63 (1) , 6-11
- https://doi.org/10.1111/j.1423-0410.1992.tb01211.x
Abstract
Effects of time, temperature, pH and stabilizers (i.e. medium) on inactivation of lipid‐enveloped model viruses, Semliki Forest and vesicular stomatitis viruses in the production process of intravenous immunoglobulin were investigated on a laboratory scale. The lowering of pH, the raising of temperature and the increasing of incubation time improved the inactivation effect. However, small changes in pH and stabilizer concentrations did not influence the results. Inactivation was not linear and a clear tailing off could be seen. Therefore, for complete virus inactivation incubation times longer than 20 h are necessary. Inactivation took place much more rapidly in intravenous immunoglobulin solution than in intramuscular immunoglobulin solution. Processing steps such as freeze‐dying in the presence of ethanol or storage of intramuscular immunoglobulin in the liquid state at pH 7 only partially inactivated these viruses.Keywords
This publication has 21 references indexed in Scilit:
- Prospective Study on the Hepatitis Safety of Intravenous Immunoglobulin, pH 4.25Vox Sanguinis, 1991
- Transmission of Non‐A, Non‐B Hepatitis by pH4‐Treated Intravenous ImmunoglobulinVox Sanguinis, 1989
- Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiencyThe American Journal of Medicine, 1988
- The viral safety of intravenous immunoglobulinJournal of Infection, 1987
- Elimination of Viruses (Human Immunodeficiency, Hepatitis B, Vesicular Stomatitis and Sindbis Viruses) from an Intravenous Immunoglobulin PreparationVox Sanguinis, 1987
- NON-A, NON-B HEPATITIS AFTER INTRAVENOUS GAMMAGLOBULINThe Lancet, 1986
- NON-A, NON-B HEPATITIS AND INTRAVENOUS IMMUNOGLOBULINThe Lancet, 1985
- NON-A, NON-B HEPATITIS OCCURRING IN AGAMMAGLOBULINAEMIC PATIENTS AFTER INTRAVENOUS IMMUNOGLOBULINThe Lancet, 1984
- NON-A, NON-B HEPATITIS FROM INTRAVENOUS IMMUNOGLOBULINThe Lancet, 1983
- Intravenous Administration of Human γ‐Globulin*Vox Sanguinis, 1962